ANIP — ANI Pharmaceuticals Inc · rev $883.4M

ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.

Latest reported ANIP revenue for 2025-12-31 was $883.4M. Net income was $78.3M. ANIP currently screens at market cap $1.41B.

Use this ANIP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ANIP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ANIP SEC filings page. Lician reads the product cache first so this HTML stays unique to ANI Pharmaceuticals Inc even when a live quote feed is slow.

ANI Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full ANIP income, balance, and cash tables.

  • Revenue$883.4M
  • Net Income$78.3M
  • Total Assets$1.44B
  • Total Debt$0
  • Free Cash Flow$171.4M

ANIP recent filings